{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:44:05Z","timestamp":1791571445427,"version":"4.3.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ejps.2014.07.013","type":"journal-article","created":{"date-parts":[[2014,8,8]],"date-time":"2014-08-08T20:45:56Z","timestamp":1407530756000},"page":"204-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":144,"special_numbering":"C","title":["Preparation and in vitro\u2013in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis"],"prefix":"10.1016","volume":"63","author":[{"given":"Neslihan","family":"\u00dcst\u00fcnda\u011f-Okur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evren Homan","family":"G\u00f6k\u00e7e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu \u0130nci","family":"Bozb\u0131y\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sait","family":"E\u011frilmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zgen","family":"\u00d6zer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6khan","family":"Ertan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2014.07.013_b0005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2005.11.020","article-title":"W\/O microemulsions for ocular delivery: evaluation of ocular irritation and precorneal retention","volume":"111","author":"Alany","year":"2006","journal-title":"J. Cont. Rel."},{"key":"10.1016\/j.ejps.2014.07.013_b0010","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1211\/0022357022476","article-title":"The potential of chitosan in ocular drug delivery","volume":"55","author":"Alonso","year":"2003","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejps.2014.07.013_b0015","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1208\/s12249-009-9268-4","article-title":"Nanoemulsion as a potential ophthalmic delivery systems for dorzolamide hydrochloride","volume":"10","author":"Ammar","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2014.07.013_b0025","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.nano.2009.02.003","article-title":"Nanomedicines for ocular NSAIDs: safety on drug delivery","volume":"5","author":"Araujo","year":"2009","journal-title":"Nanomed-Nanotechnol."},{"key":"10.1016\/j.ejps.2014.07.013_b0030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.colsurfb.2011.06.025","article-title":"Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye","volume":"88","author":"Ara\u00fajo","year":"2011","journal-title":"Colloid Surface B"},{"key":"10.1016\/j.ejps.2014.07.013_b0020","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.nano.2011.10.015","article-title":"Release profile and transscleral permeation of triamcinolone acetonide loaded nanostructured lipid carriers (TA-NLC): in vitro and ex vivo studies","volume":"8","author":"Ara\u00fajo","year":"2012","journal-title":"Nanomed-Nanotechnol."},{"key":"10.1016\/j.ejps.2014.07.013_b0035","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijpharm.2007.12.007","article-title":"Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct","volume":"355","author":"Attama","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.07.013_b0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0168-3659(02)00284-5","article-title":"Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI) for the treatment of external ocular infections in dogs","volume":"85","author":"Baeyens","year":"2002","journal-title":"J. Cont. Rel."},{"key":"10.1016\/j.ejps.2014.07.013_b0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0022-0248(88)90294-1","article-title":"Crystallization mechanisms in solution","volume":"90","author":"Boistelle","year":"1988","journal-title":"J. Cryst. Growth."},{"key":"10.1016\/j.ejps.2014.07.013_b0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.talanta.2013.10.054","article-title":"Rapid immunochromatographic assay for ofloxacin in animal original foodstuffs using native antisera labeled by colloidal gold","volume":"119","author":"Byzovaa","year":"2014","journal-title":"Talanta"},{"key":"10.1016\/j.ejps.2014.07.013_b0055","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jconrel.2005.09.040","article-title":"Deoxycholic acid-conjugated chitosan oligosaccharide nanoparticles for efficient gene carrier","volume":"109","author":"Chae","year":"2005","journal-title":"J. Cont. Rel."},{"key":"10.1016\/j.ejps.2014.07.013_b0060","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1023\/B:PHAM.0000026432.75781.cb","article-title":"Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity","volume":"21","author":"de Campos","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2014.07.013_b0065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2003.12.018","article-title":"Effect of chitosan and of n-carboxymethylchitosan on intraocular penetration of topically applied ofloxacin","volume":"273","author":"Di Colo","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.07.013_b0070","first-page":"36","article-title":"Triangle phase diagram analysis software. In: Presented at: The 4th International Postgraduate Research Symposium on Pharmaceutics","volume":"46","author":"Ege","year":"2009","journal-title":"\u0130stanbul-Turkey"},{"key":"10.1016\/j.ejps.2014.07.013_b0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijpharm.2013.11.025","article-title":"Design of cationic lipid nanoparticles for ocular delivery: development, characterization and cytotoxicity","volume":"461","author":"Fangueiro","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.07.013_b0085","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0378-5173(99)00003-4","article-title":"Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention","volume":"180","author":"Felt","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.07.013_b0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/jop.2000.16.261","article-title":"Chitosan as tear substitute: a wetting agent endowed with antimicrobial efficacy","volume":"16","author":"Felt","year":"2000","journal-title":"J. Ocular Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2014.07.013_b0090","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1016\/j.carbpol.2011.11.027","article-title":"In vitro drug permeation from chitosan pellets","volume":"87","author":"Ferrari","year":"2012","journal-title":"Carbohyd. Polym."},{"issue":"2","key":"10.1016\/j.ejps.2014.07.013_b0095","first-page":"11","article-title":"Chitosan coated Plga-microspheres \u2013 a modular system for targeted drug delivery","volume":"7","author":"Fischer","year":"2004","journal-title":"Eur. Cells Mater."},{"issue":"11","key":"10.1016\/j.ejps.2014.07.013_b0100","first-page":"52","article-title":"Solid lipid nanospheres from warm micro-emulsions","volume":"9","author":"Gasco","year":"1997","journal-title":"Pharm. Technol. Eur."},{"key":"10.1016\/j.ejps.2014.07.013_b0105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejpb.2003.10.018","article-title":"PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification\/spray-drying as the preparation method: in vitro\/in vivo studies","volume":"57","author":"Gavini","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2014.07.013_b0110","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijpharm.2008.07.028","article-title":"Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity","volume":"364","author":"G\u00f6k\u00e7e","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.07.013_b0115","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.2147\/IJN.S29710","article-title":"Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications","volume":"7","author":"G\u00f6kce","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejps.2014.07.013_b0120","first-page":"373","article-title":"The pH tolerance of rabbit and human corneal endothelium","volume":"18","author":"Gonnering","year":"1979","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.ejps.2014.07.013_b0125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/10611860903338462","article-title":"Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system","volume":"18","author":"Kalam","year":"2010","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejps.2014.07.013_b0130","series-title":"The Cornea","author":"Kaufman","year":"1988"},{"issue":"4","key":"10.1016\/j.ejps.2014.07.013_b0135","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2478\/acph-2013-0039","article-title":"Development and evaluation of coenzyme Q10 loaded solid lipid nanoparticle hydrogel for enhanced dermal delivery","volume":"63","author":"Korkmaz","year":"2013","journal-title":"Acta Pharmaceut."},{"key":"10.1016\/j.ejps.2014.07.013_b0140","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.addr.2009.11.026","article-title":"Chitosan-based nanostructures: a delivery platform for ocular therapeutics","volume":"62","author":"la Fuente","year":"2010","journal-title":"Adv Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2014.07.013_b0160","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijpharm.2008.07.017","article-title":"A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers","volume":"363","author":"Li","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.07.013_b0150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijpharm.2009.06.020","article-title":"Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery","volume":"379","author":"Li","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejps.2014.07.013_b0155","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nmat2915","article-title":"A polycationic antimicrobial and biocompatible hydrogel with microbe membrane suctioning ability","volume":"10","author":"Li","year":"2011","journal-title":"Nat Mater."},{"key":"10.1016\/j.ejps.2014.07.013_b0145","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijpharm.2013.04.018","article-title":"Comparison of systemic absorption between ofloxacin ophthalmic in situ gels and ofloxacin conventional ophthalmic solutions administration to rabbit eyes by HPLC\u2013MS\/MS","volume":"450","author":"Li","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.07.013_b0165","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.addr.2005.07.005","article-title":"The use of mucoadhesive polymers in ocular drug delivery","volume":"57","author":"Ludwig","year":"2005","journal-title":"Adv. Drug Deliver. Rev."},{"key":"10.1016\/j.ejps.2014.07.013_b0170","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpharm.2010.10.013","article-title":"Nanostructured lipid carrier (NLC) coated with chitosan oligosaccharides and its potential use in ocular delivery systems","volume":"403","author":"Luo","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.07.013_b0175","first-page":"221","article-title":"Nanoparticle characterization: a comprehensive physicochemical approach","volume":"1","author":"Magenheim","year":"1991","journal-title":"STP Pharma. Sci."},{"key":"10.1016\/j.ejps.2014.07.013_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/680642","article-title":"Animal models of bacterial keratitis","volume":"680642","author":"Marquart","year":"2011","journal-title":"J Biomed. Biotechnol."},{"issue":"4","key":"10.1016\/j.ejps.2014.07.013_b0185","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0142-9612(96)00144-5","article-title":"Influence of sterilization processes on poly(epsilon-caprolactone) nanospheres","volume":"18","author":"Masson","year":"1997","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2014.07.013_b0190","first-page":"511","article-title":"Solid Lipid Nanoparticles (SLN)\u2014ein neuartiger Wirkstoff-Carrier fur Kosmetika und Pharmazeutika. II. Wirkstoff-Inkorporation, Freisetzung und Sterilizierbarkeit","volume":"59","author":"Mehnert","year":"1997","journal-title":"Pharm Ind"},{"key":"10.1016\/j.ejps.2014.07.013_b0195","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery\u2014a review of the state of the art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2014.07.013_b0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bfopcu.2013.04.004","article-title":"Determination of ofloxacin and dexamethasone in Dexaflox eye drops through different ratio spectra manipulating methods","volume":"51","author":"Nebsen","year":"2013","journal-title":"Bull. Fac. Pharm., Cairo Univ."},{"key":"10.1016\/j.ejps.2014.07.013_b0205","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.colsurfb.2012.12.014","article-title":"Influence of antimicrobial additives on the formation of rosin nanofibers via Electrospinning","volume":"104","author":"Nirmalaa","year":"2013","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.ejps.2014.07.013_b0210","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.micres.2006.07.004","article-title":"Comparative trial of different anti-bacterial combinations with propolis and ciprofloxacin on Pseudomonas keratitis in rabbits","volume":"162","author":"Onlen","year":"2007","journal-title":"Microbiol Res."},{"issue":"12","key":"10.1016\/j.ejps.2014.07.013_b0215","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1128\/AEM.00453-08","article-title":"Insights into the mode of action of chitosan as an antibacterial compound","volume":"74","author":"Raafat","year":"2008","journal-title":"Appl. Environ. Microbiol."},{"issue":"6","key":"10.1016\/j.ejps.2014.07.013_b0220","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1021\/bm034130m","article-title":"Chitosan as antimicrobial agent: applications and mode of action","volume":"4","author":"Rabea","year":"2003","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejps.2014.07.013_b0225","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ejpb.2009.02.006","article-title":"Bioadhesive sulfacetamide sodium microspheres: Evaluation of their effectiveness in the treatment of bacterial keratitis caused by Staphylococcus aureus and Pseudomonas aeruginosa in a rabbit model","volume":"72","author":"Sensoy","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2014.07.013_b0240","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jconrel.2009.04.021","article-title":"Mucoadhesive effect of thiolated PEG stearte and its modified NLC for ocular drug delivery","volume":"137","author":"Shen","year":"2009","journal-title":"J. Cont. Rel."},{"key":"10.1016\/j.ejps.2014.07.013_b0230","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijpharm.2010.10.008","article-title":"Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: Improving in vivo ocular distribution","volume":"402","author":"Shen","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.07.013_b0235","doi-asserted-by":"crossref","first-page":"025101","DOI":"10.1088\/0957-4484\/21\/2\/025101","article-title":"Incorporation of liquid lipid in lipid nanoparticles for ocular drug delivery enhancement","volume":"21","author":"Shen","year":"2010","journal-title":"Nanotechnology"},{"key":"10.1016\/j.ejps.2014.07.013_b0245","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-3-642-00477-3_4","article-title":"Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes","author":"Souto","year":"2010","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ejps.2014.07.013_b0250","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijpharm.2004.02.032","article-title":"Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery","volume":"278","author":"Souto","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.07.013_b0255","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/0887-2333(90)90146-K","article-title":"Comparison of two in vitro and two in vivo methods for the measurement of irritancy, Toxicol","volume":"4","author":"Sterzel","year":"1990","journal-title":"In Vitro"},{"issue":"7","key":"10.1016\/j.ejps.2014.07.013_b0260","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.actbio.2010.01.002","article-title":"Antibacterial action of a novel functionalized chitosan-arginine against Gram-negative bacteria","volume":"6","author":"Tang","year":"2010","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.ejps.2014.07.013_b0265","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejpb.2007.01.015","article-title":"Cetyl palmitate-based nlc for topical delivery of coenzyme Q10 \u2013 development, physicochemical characterization and in vitro release studies","volume":"67","author":"Teeranachaideekul","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2014.07.013_b0270","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.colsurfb.2012.08.021","article-title":"Further investigation of nanostructured lipid carriers as an ocular delivery system: In vivo transcorneal mechanism and in vitro release study","volume":"102","author":"Tian","year":"2013","journal-title":"Colloid Surf. B"},{"key":"10.1016\/j.ejps.2014.07.013_b0275","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.powtec.2013.07.010","article-title":"Solidification of nanostructured lipid carriers (NLCs) onto pellets by fluid-bed coating: preparation, in vitro characterization and bioavailability in dogs","volume":"247","author":"Tian","year":"2013","journal-title":"Powder Technol."},{"key":"10.1016\/j.ejps.2014.07.013_b0280","article-title":"Novel ofloxacin loaded microemulsion formulations for ocular delivery","author":"\u00dcst\u00fcnda\u011f-Okur","year":"2013","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2014.07.013_b0285","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1350-9462(01)00017-9","article-title":"Microemulsions as ocular drug delivery systems: recent developments and future challenges","volume":"21","author":"Vandamme","year":"2002","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejps.2014.07.013_b0290","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jconrel.2006.07.023","article-title":"Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs","volume":"115","author":"Wang","year":"2006","journal-title":"J. Cont. Rel."},{"key":"10.1016\/j.ejps.2014.07.013_b0295","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.colsurfa.2007.04.067","article-title":"Production of drug-loaded lipid nanoparticles based on phase behaviors of special hot microemulsions","volume":"313\u2013314","author":"Xia","year":"2008","journal-title":"Colloid Surf. A"},{"key":"10.1016\/j.ejps.2014.07.013_b0300","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijpharm.2005.05.036","article-title":"Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate","volume":"301","author":"Yamaguchi","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2014.07.013_b0305","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0378-5173(94)90243-7","article-title":"Hydrocortisone delivery to healthy and inflamed eyes using a micellar polysorbate 80 solution or albumin nanoparticles","volume":"110","author":"Zimmer","year":"1994","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098714003091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098714003091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T18:46:13Z","timestamp":1565721973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098714003091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":61,"alternative-id":["S0928098714003091"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2014.07.013","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparation and in vitro\u2013in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2014.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}